Proximity to fracking sites associated with risk of childhood cancer
Pennsylvania children living near unconventional oil and gas (UOG) developments at birth were two to three times more likely to be diagnosed with leukemia between the ages of 2 and 7 than those who did not live near this oil and gas activity, after accounting for other factors that could influence cancer risk, a novel study from the Yale School of Public Health finds.Source: Yale News
National Committee for Accreditation Program for Rectal Cancer Names Dhanpat Jain, MD, to its Quality Assurance Committee
The National Committee for Accreditation Program for Rectal Cancer (NAPRC) has named Dhanpat Jain, MD, Professor of Pathology and of Medicine (Digestive Diseases), to represent the College of American Pathologists on the NAPRC’s Quality Assurance Committee.
Rimm Lab Validates Objective Prognostic Marker in Patients With Early-stage Melanoma
An objective assessment of automated electronic tumor infiltrating lymphocytes percentage (eTILs%) scores is a strong prognostic marker in patients with early-stage melanoma. The study also identifies distinct TIL subpopulations that carry the prognostic values.
Using Particles That Are Smaller Than the Head of a Pin to Treat Cancer
Thanks in part to research begun more than a decade ago with funding from Women’s Health Research at Yale, Dr. W. Mark Saltzman is working with colleagues on a way to deploy effective cancer-fighting medication safely with the help of nanoparticles.
Dhanpat Jain, MD, Appointed to Cancer Committee of College of American Pathologists
Dhanpat Jain, MD, Professor of Pathology and of Medicine (Digestive Diseases), has been named to the Cancer Committee of the College of American Pathologists (CAP), the leading organization of board-certified pathologists that fosters and advocates excellence in the practice of pathology and laboratory medicine worldwide.
Yale Pathology to be Represented at the Pulmonary Pathology Society Meeting in Cork, Ireland
Sanja Dacic, MD, PhD, Vice Chair and Director of Anatomic Pathology at Yale Pathology and president of the Pulmonary Pathology Society (PPS), will be accompanied by the Yale Thoracic Pathology Service team at the PPS Biennial Meeting June 25-27 in Cork, Ireland.
Irina Krykbaeva, PhD, Awarded 2022 Milton C. Winternitz Prize in Pathology
Irina Krykbaeva, a recent PhD graduate in the Department of Pathology at Yale School of Medicine, is the winner of the 2022 Milton C. Winternitz Prize in Pathology. The prize is awarded annually to the student who, in the opinion of the department faculty and staff, has done outstanding work in the course.
Oncologist: More cancers detected in later, deadlier stages due to lack of routine tests
Doctors at Yale Cancer Center say early detection has been harder during COVID-19. Yale Cancer Center Director Dr. Eric Winer says there's no doubt cancer screenings were down during the pandemic. Doctors say women over 50 should get a mammogram every two years. Every 10 years, men and women over 50 need the less popular screening, colonoscopies. "Colonoscopies, which not only detect cancers, but sometimes treat pre-cancerous lesions and prevent the development of cancer," said Winer. Winer says if you deferred your scans to stay away from the hospital during the pandemic, you shouldn't delay any longer.Source: News12
Yale Pathology Diagnostic Pathology CME Annual Review Scheduled for September 17-18 at Yale Club of NYC
The Yale Department of Pathology presents its inaugural Diagnostic Pathology CME Annual Review on September 17-18 at the Yale Club of New York City. This inaugural course at the Yale Club in the heart of Midtown Manhattan will focus on the recent World Health Organization updates in all major pathology subspecialties.
Yale Study Identifies Causes of Cancers
A team of Yale-led researchers can now quantify the factors causing changes in the DNA that contribute most to cancer growth in tumors of most major tumor types. Their molecular analysis approach brings clarity to a longstanding debate over how much control humans have over developing cancer over time.